Abstract
Genetically modified herbicide-tolerant (GMHT) crops are being grown in many parts of the world. The EU will soon make a decision on their commercialization in Europe. It is not easy for legislators to reach conclusions as to the risks and benefits. This paper looks at the information emerging from countries where these GMHT crops are already commercialized, and identifies the benefits and problems. It then looks at issues especially relevant to the UK and not fully covered by the field experiences elsewhere, and where specific European research projects have endeavoured to find answers. It seeks to identify the benefits and the real problems for the UK that need to be resolved prior to commercialization.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
